Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GSK 1557484A H5N1 Vaccine in Adults
NCT00616928Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2008
- Primary completion
- Oct 2008
- Modality
- Whole Inactivated Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted in Influenza A H5N1 (H5N1), sponsored by GSK. Started Jan 2008; status: completed.
02
Drugs
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
03
Conditions
Influenza A H5N1 (H5N1)
Beyond the preview
Go deeper on NCT00616928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616928.